December 16, 2024, Intelligence Late-Breaking Lab News

By Robert Michel | From the Volume XXXI, No. 17 – December 16, 2024 Issue

Sonic Healthcare Ltd of Sydney, Australia, announced the acquisition of clinical laboratory company LADR (Laboratory Group Dr. Kramer & Colleagues) based in Geesthacht, Germany, on Dec. 9, 2024. The enterprise value of the deal is €423 million (US$446.9 million…

Read More

---

Global IVD Companies Issue Third Quarter 2024 Earnings

By Robert Michel | From the Volume XXXI, No. 16 – November 25, 2024 Issue

HERE IS A SUMMARY OF THE THIRD QUARTER FINANCIAL PERFORMANCE of t…

Read More

---

October 14, 2024, Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXXI, No. 14 – October 14, 2024 Issue

Babson Diagnostics of Austin, Texas, received a “strategic investment” from Becton, Dickinson and Company (BD). The amount of the investment was not disclosed. In the past year, Babson launched an innovative lab testing service with retail pharmacies in Austin an…

Read More

---

2023 Ranking of the World’s Top 13 IVD Corporations

By Robert Michel | From the Volume XXXI, No. 10 – July 22, 2024 Issue

BASED ON 2023 DIAGNOSTICS-RELATED REVENUE, four in vitro diagnostics (IVD) manufacturers continued to lead the global IVD market just as they did in 2022. They are: Thermo Fisher Scientific, Inc., Roche Holdings, Abbott Laboratories, and Danaher Corporation. Th…

Read More

---

July 22, 2024, Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXXI, No. 10 – July 22, 2024 Issue

Some hospitals failing to comply with the federal price transparency regulation have been fined. The website of CMS.gov lists 15 hospitals and the amount each was fined. On June 6, 2022, the first fines were levied against Northside Hospital of Atlanta ($883,130) and Northsid…

Read More

---

Global IVD Companies Report First Quarter 2024 Earnings

By Robert Michel | From the Volume XXXI, No. 9 – July 1, 2024 Issue

IN THEIR INITIAL FINANCIAL REPORTING F…

Read More

---

Most IVD Firms Increase Q3 2023 Base Business Revenue

By Robert Michel | From the Volume XXX, Number 17 – December 4, 2023 Issue

Most in vitro diagnostics (IVD) companies reported increases in base business during the third quarter (Q3) 2023. The numbers, in the single digits, softened the blow from the continuing drop-off in COVID-19 test sales. Manufacturers of tests and laboratory instruments are launching ne…

Read More

---

October 2, 2023, Intelligence: Late-Breaking Lab News

By Scott Wallask | From the Volume XXX, No. 14 – October 2, 2023 Issue

Forming new relationships with non-traditional care providers is one way clinical laboratories can earn additional revenue. With that in mind, here’s another sign of the changing landscape of primary care. Warehou…

Read More

---

Don’t Automate Bad Work Processes in Microbiology

By Scott Wallask | From the Volume XXX, No. 13 – September 11, 2023 Issue

CEO SUMMARY: Automation is not always right for every lab’s microbiology department, according to consultants from bioMérieux. When evaluating automated instruments, it is necessary to review wo…

Read More

---

July 31, 2023, Intelligence: Late-Breaking Lab News

By Scott Wallask | From the Volume XXX, No. 11 – July 31, 2023 Issue

Regulatory relief is on the way for clinical laboratories accredited by The Joint Commission. An overhaul of the Laboratory Accreditation Program’s standards, which goes into effect Aug. 27, will …

Read More

---